eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2018
vol. 56
 
Share:
Share:
more
 
 
abstract:
Original paper

The impact of chronic intermittent hypoxia on the expression of intercellular cell adhesion molecule-1 and vascular endothelial growth factor in the ischemia-reperfusion rat model

Meili Yang, Yafang Chen, Zhengang Wu, Yaping Zhang, Ruowei Cai, Lichao Ye, Yinhui Huang, Lingxing Wang, Huiling He

Folia Neuropathol 2018; 56 (3): 159-166
Online publish date: 2018/09/28
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The aim of this study was to investigate the effect and mechanism of chronic intermittent hypoxia (CIH) on cerebral injury using the ischemia-reperfusion rat model. In total, 36 SD rats were divided into three groups: pseudo-surgery group (sham group), ischemia-reperfusion (IR) group (CIR group), and CIH intervention group (CIH group). The IR model was established using the suture-occluded method. CIH intervention was performed starting at 12 weeks prior to the establishment of the IR model for rats in the CIH group. Ultra-microstructure was examined using an electron microscope. Expression of intercellular cell adhesion molecule-1 (ICAM-1) and vascular endothelial growth factor (VEGF) in rat brain tissue was evaluated by immunohistochemical methods and western blot assays. The neurological deficit scores of rats in the CIH group were higher than those in the CIR group (p < 0.05). Using electron microscopy, we observed more severe edema around the capillaries of the rat brain that resulted in more pressure on the vascular wall of the capillaries in the CIH group compared to the CIR group. The expression of ICAM-1 and VEGF in rat brain tissue was rare in the sham group, but was significantly elevated in the CIR group (p < 0.05) and even higher in the CIH group, compared to the CIR group. Hence, the brain injury in ischemia-reperfusion rat models following CIH intervention may be related to the increased expression of ICAM-1 and VEGF.
keywords:

chronic intermittent hypoxia, ischemic reperfusion injury, ICAM-1, VEGF

references:
Aaronson JA, van Bennekom CA, Hofman WF, van Bezeij T, van den Aardweg JG, Groet E, Kylstra WA, Schmand B. Obstructive sleep apnea is related to impaired cognitive and functional status after stroke. Sleep 2015; 38: 1431-1437.
Arnaud C, Beguin PC, Lantuejoul S, Pepin JL, Guillermet C, Pelli G, Burger F, Buatois V, Ribuot C, Baguet JP, Mach F, Levy P, Dematteis M. The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Resipir Crit Care Med 2011; 184: 724-731.
Attal P, Chanson P. Endocrinea spects of obstructive sleep apnea. J Clin Endorinol Metab 2010; 95: 483-495.
Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. J Respir Crit Care Med 2002; 165: 934-939.
Eltzschig HK, Eckle T. Ischemia and reperfusion from mechanism to translation. Nat Med 2011; 17: 1391-1401.
Feng J, Zhang D, Chen B. Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 2012; 16: 283-294.
Guven SF, Turkkani MH, Ciftci B, Ciftci TU, Erdogan Y. The relationship between high sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath 2012; 16: 217-221.
Hamanaka J, Hara H. Involvement of Toll-like receptors in ischemia-induced neuronal damage. Cent Nerv Syst Agents Med Chem 2011; 11: 107-113.
Hamann GF, del Zoppo GJ. The cerebral microvasculature and responses to ischemia. Stroke 2004; 38: 775-783.
Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. Thephosphatidylinositol-3 kinase/Akt pathway mediates VEGF’s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 2006; 20: 1185-1187.
King S, Cuellar N. Obstructive sleep apnea as an independent stroke risk factor: A review of the evidence, stroke prevention guidelines, and implications for neuroscience nursing practice. J Neurosci Nurs 2016; 48: 133-142.
Kulkas A, Tiihonen P, Eskola K, Julkunen P, Mervaala E, Töyräs J. Novel parameters for evaluating severity of sleep disordered breathing and supporting diagnosis of sleep apnea-hyponea sysdrom. J Med Eng Technol 2013; 37: 135-143.
Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 2005; 23: 1059-1075.
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
Mehra R, Bena J, Walia HK. Clarifying the Role of Hypoxia in Obstructive Sleep Apnea as a Potential Promulgator of Atrial Fibrillation in Ischemic Stroke. J Clin Sleep Med 2017; 13: 667-668.
Meschia JF, Bushnell C, Boden-AlbalaB, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension. Guidelines for the primary Prevention of stroke: a statement for healthcare professionals from the American Heart Association/American stroke Association. Stroke 2014; 45: 3754-3832.
Min S, Huang J, Li J, Qin X, Tang X, Jin F, Chen S, Jiang C, Zou Z, Peng K, Nuruzzaman M, Zhang J, Luo J, Liu S, Luo Z. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling. Oncotarget 2016; 7: 19018-19030.
Nava-Guerra L, Tran WH, Chalacheva P, Loloyan S, Joshi B, Keens TG, Nayak KS, Davidson Ward SL, Khoo MC. Model-based stability assessment of ventilatory control in overweight adolescents with obstructive sleep apnea during NREM sleep. J Appl Physiol (1985) 2016; 121: 185-197.
Neubauer JA. Invited review: Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol (1985) 2001; 90: 1593-1599.
Ryan S, McNicholas WT. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 2008; 114: 261-266.
Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA. Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med 2008; 168: 297-301.
Turmel J, Sériès F, Boulet LP, Poirier P, Tardif JC, Rodés-Cabeau J, Larose E, Bertrand OF. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 2009; 132: 203-209.
Unnikrishnan D, Jun J, Polotsky V. Inflammation in sleep apnea: an update. Rev Endocr Metab Disord 2015; 16: 25-34.
Vemuganti R, Dempsey RJ, Bowen KK. Inhibition of intercellular adhesion molecule-l protein expression by antisense oligonueleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke 2004; 35: 179-184.
Voherra A, Meldolesi J. Astrocytes, from brain glue to communication elements the revolution continues. Nat Rev Neurosci 2005; 6: 626-640.
Wang XS, MIAO L, Yao XM, Zhu XL. The ultrastructural changes of blood-brain barrier after cerebral ischemia reperfusion in rats. Tianiin Med J 2006; 34: 188-189.
Xu XM, Yao D, Cai XD, Ding C, Lin QD, Wang LX, Huang XY. Effect of chronic continual-and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breath 2015; 19: 677-684.
Zamarrón C, Riveiro A, Gude F. Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Arch Med Sci 2011; 7: 1023-1028.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe